IMP

Process View

8 genes annotated in human

doxorubicin metabolic process

The chemical reactions and pathways involving doxorubicin, an anthracycline antibiotic, used in cancer chemotherapy.

Loading network...

In addition to gene-name show these genes:

Known genes in the process in human Include functional analogs

Minimum relationship confidence:

Maximum number of genes:

Highlight known relationships in gold.

Adjust edge length:

Adjust node size:

Fixed layout

Black background

Low confidence color:

Med confidence color:

High confidence color:

Hide the legend in the network

Click on a gene's description to view its network relationships with genes known to be involved in "doxorubicin metabolic process"

Show only novel predictions Show only unknown genes Highlight genes with functional analogs involved in "doxorubicin metabolic process" (in gray)

Name	Description	Probability	Func Analog Organism
AKR1C3	aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)	0.998
AKR7A3	aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)	0.985	Human
AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	0.959
AKR1C2	aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III)	0.929
AKR1C1	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	0.796
PRMT2	protein arginine methyltransferase 2	0.050
ZHX1	zinc fingers and homeoboxes 1	0.037
IDH2	isocitrate dehydrogenase 2 (NADP+), mitochondrial	0.024